A modestly sized clinical trial indicates that PCSK9-inhibitors can help lower cholesterol, even for those who experienced side effects with older drugs.
Shantell M. Kirkendoll
Shantell M. Kirkendoll is the senior communication representative for the University of Michigan Health System. She leverages social media and media relations to tell compelling stories about research and health care. She was a Knight Journalism Fellow at the Centers for Disease Control and Prevention and joined the University of Michigan Health System in 2009. Prior to that she was a print journalist for 20 years.
In a first-of-its-kind study in the U.S., individuals with irritable bowel syndrome showed an improvement in symptoms and quality of life compared to a control.
Three clinical trials are investigating which of two screenings — colonoscopy or a lower-cost stool-based test — is more effective at saving lives.
Access to health care for veterans with liver disease is highlighted in a new paper, which links visits to specialists with improved treatment outcomes.
Doctors of Tomorrow pairs first-year medical students with ninth-grade mentees to foster diversity in medical fields.